Tequin (gatifloxacin) is now contraindicated for diabetes patients

Tequin (gatifloxacin) is now contraindicated for diabetes patients.

In January, we told you about the many reports of hyper- and hypoglycemia associated with Tequin...especially in diabetes patients.

Also watch for patients at risk for blood glucose problems with Tequin due to advanced age or renal insufficiency.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote